NEUARTIGE ANTI-PD-1-ANTIKÖRPER

European patent · EP3334763 · In force

Register entry

Publication number
EP3334763
Application number
EP16834675
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 11, 2016
Published
Jun 20, 2018
Granted
Aug 7, 2024
Protection ends at the latest
Aug 10, 2036
Next annual fee due
Aug 31, 2027
IPC classes
C07K 16/28 (2006.01)
A61K 39/395 (2006.01)
A61P 35/00 (2006.01)
Priority
WO PCT/CN2015/086594 11.08.2015
WO PCT/CN2016/071374 19.01.2016
PCT application
PCT/CN2016/094624 11.08.2016
PCT publication
WO2017/025051 16.02.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Nov 24, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 24.11.2025

  3. Jun 18, 2025

    Change

    Published in Swissreg on 18.06.2025

  4. Oct 26, 2024

    Agent entered

    Representative
    E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 26.10.2024

  5. Oct 9, 2024

    Change

    Published in Swissreg on 09.10.2024

  6. Aug 7, 2024

    Granted

    Published in Swissreg on 07.08.2024

Parties

Holder

WuXi Biologics Ireland Limited

One Spencer Dock North Wall Quay, Dublin 1, IE

Agent

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

Inventor

LI, Jing

Lexington, Massachusetts 02420, US

ZHENG, Yong

Shanghai 201203, CN

CHEN, Zhisheng

Shanghai 200131, CN

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.